Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Charles Lockwood, MD, Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Services, Yale School of Medicine, discusses research initiatives looking at placental abruption and how it triggers…
Todd Schaeffer, MD, FACS, Assistant Clinical Professor of Otolaryngology, Mount Sinai School of Medicine, New York University School of Medicine, discusses endoscopic techniques and the use of direct…
Marsha Guess, MD, Assistant Professor of Obstetrics, Gynecology and Reproductive Services, Yale University, discusses pelvic organ prolapse in relation to vaginal birth versus cesarean section and summarizes that…
Emre Ui Seli, MD, Assistant Professor and Director Third Party Reproduction Program, Yale School of Medicine, discusses IVF, in vitro fertilization, which is the best treatment for infertility…
Emre U. Seli, MD, Assistant Professor and Director Third Party Reproduction Program, Yale School of Medicine, discusses IVF, the use of egg donors for women who cannot produce…
NEW YORK (Reuters Health) – Having a first-degree relative with breast cancer may slightly increase a person’s risk of colorectal cancer, Canadian researchers report in the International Journal…
NEW YORK (Reuters Health) – Therapy with denosumab appears to augment bone mineral density and lower the risk of fracture among men with prostate cancer undergoing androgen-deprivation therapy,…
NEW YORK (Reuters Health) – Don’t assume that lower limb salvage yields better functional and quality-of-life outcomes than amputation for children and adolescents with bone and soft tissue…
NEW YORK (Reuters Health) – Ovarian- and uterine-conserving surgery appears to be safe in premenopausal women with stage IA or IC epithelial ovarian cancer, with no adverse impact…
NEW YORK (Reuters Health) – Cardiac troponin-I is superior to electrocardiogram and creatinine kinase MB for predicting myocardial injury after coronary artery bypass graft (CABG) surgery, results of…
